Komori
Heartseed (219A) · InitiativeFirst stated

Raising funds through the issuance of shares at listing

First written in FY2024. . Latest entry: FY2024.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Fundraising for Pharmaceutical Development through New Share Issuances, Out-Licensing and Other MeansA theme 19 companies write about · 0 as a headwind · 25 as a tailwind

0 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 19 companies compared. The sentences above are computed from all 19.
Full recordFilings, disclosures and news, newest first
  1. FY2024First statedAnnual report

    「Public offering for cash (offering using the book-building method)」

    The Company raised R&D funding through a public offering and a third-party allotment associated with an overallotment.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Heartseed yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Raising funds through the issuance of shares at listing | Heartseed Inc. (219A) | Komori